Peak Partners Holding AG https://validator.w3.org/feed/docs/rss2.html About Us Industrial / Engineering Technology Ayar Labs Closes $500M Series E Biotech / Life Sciences CREAL’s breakthrough AR display: real depth with a classic lens Peak Partners News SkyCell closes US$116 million Series D CUTISS announces first closing of CHF 25M in Series C funding round CUTISS continues collaboration with Santobono Hospital in Naples Home Immunophotonics Announces 1st Patient Dosed in a Randomised Phase 2 Study at the University of Louisville Breitling joins forces with Climeworks Ayar Labs Bets on Silicon Photonic Technology and Taiwan’s Chip Ecosystem Information Technology betPawa ranks first in Acquisition Power Score among iGaming brands in regulated markets for 2024 Positive Phase 2 trial readout for long-term efficacy & safety of denovoSkin™ in reconstructive skin surgery and in burns Nvidia, AMD and Intel Invest in Startup Bringing Light to Chips EMA authorizes Phase 3 clinical trial for denovoSkin™ Consumer Technology Climeworks confirms expansion to U.S. Skycell assessed for less than 0.05% temperature excursion rate Climeworks eyes Kenya project to capture carbon dioxide from air Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in France CUTISS launches Series C financing round to advance the development of its personalized skin technology SkyCell forges new partnership with Marken Climeworks, Deep Sky unveil catalytic partnership in Canada to expand carbon removal in North America Immunophotonics announces 1st patient dosed in the United States Positive Phase 2 trial interim analysis on safety and efficacy for denovoSkin™ in pediatric burn patients 3YOURMIND, JSSB Developing Digital Inventories in Oil & Gas First-ever glasses prescribed by light-field refraction test device! Immunophotonics Announces 1st Patient Dosed in Trial in Advanced Solid Tumor Indications Telerobotic experiences are reaching new heights with light-field technology Advanced testing of human skin cells on the International Space Station Youngest patient ever treated with denovoSkin – a neonatal case CUTISS announces positive Phase 2 clinical trial results for denovoSkin™ SkyCell welcomes Lazard Asset Management as a shareholder Immunophotonics receives green light from FDA to open IND study Climeworks signs 9-year agreement with the LEGO Group and KIRKBI AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy Positive one-year follow-up data from Phase 2 trial of denovoSkin™ CUTISS and Tecan partner to advance the automation of bioengineered human skin tissue manufacturing